Pune, India, May 08, 2019 (GLOBE NEWSWIRE) -- Global Stem Cell Manufacturing Market is expected to thrive at a robust CAGR of 17.5% during the assessment period 2018 to 2023. The forecast further suggests that the global market is anticipated to scale a valuation of USD 17,469.6 Mn by the close of 2023, According to Market Research Future (MRFR).
Stem cell manufacturing involves culturing of cells acquired from bone marrow or peripheral blood cells which can develop into specialized cell types. Thus, it is observing an upsurge in demand for repairing or replacing damaged cells and tissues with regenerative medicines. The accelerated adoption of regenerative medicine has unleashed growth opportunities in the market to be capitalized over the next few years.
Request Free Sample @ https://www.marketresearchfuture.com/sample_request/6942
Stem cells have paved its way across the treatment of a range of diseases and are expected to gain more traction in the upcoming years. The market is at a nascent stage, and the developments in quality engineering have attracted several global leaders to the competitive landscape. With a large fraction of the clinical trials moving towards the final phase, the growth pattern of the stem cell manufacturing market is expected to be boosted with developments in the manufacturing process.
The ongoing trend of increasing public-private investments in stem cell-based research and development is likely to prevail across the review period. This, in turn, is prognosticated to enable the stem cell manufacturing market to grow manifolds in the years to come. To illustrate, a global innovator in cell-based medicines and liver diseases, Promethera Biosciences SA, has announced the closing of series D financing worth USD 44.4 Mn which would be used for accelerating its HepaStem clinical program in ACLF in conjunction with scaling up of its manufacturing operations. However, there is a lack of enough FDA approved stem cell treatment products which is likely to undermine market growth over the review period.
Key Players:
The noted players operating in the global stem cell manufacturing market are –
- Stemcell Technologies Inc. (US)
- Fujifilm Cellular Dynamics Inc. (US)
- Becton
- Dickinson and Company (US)
- Bristol-Myers Squibb Company (US)
- Bio-Rad Laboratories, Inc (US)
- Athersys Inc (US)
- Merck KGaA (Germany)
- Lonza (Switzerland)
- HiMedia Laboratories (India)
- Thermo Fisher Scientific (US)
Market Segmentation:
This MRFR report offers a comprehensive segmental assessment of the stem cell manufacturing market based on application, product, and end-user. By application, the market has been segmented into therapy, research and cell, and tissue banking.
On the basis of product, the global stem cell manufacturing market has been segmented into stem cell lines, instruments, consumables and culture media.
The market, by end-user, has been segmented into pharmaceutical/biotechnology companies & CRO and hospitals & stem cell banks.
Rising incidences of cancer expected to drive market growth in the Americas
The regional analysis of the global Stem Cell Manufacturing Market spans across four regions - Americas, Europe, Asia Pacific, and the Middle East and Africa (MEA). Americas houses developed biotechnology and pharmaceutical industries which are expected to catalyze the expansion of the stem cell manufacturing market in the region. Also, the increasing burden of cancer is poised to fuel demand for developments in stem cell therapies, thus, augmenting the market. The forecast further projects that Asia Pacific is presumed to strike a relatively higher CAGR and exhibit a steeper growth curve over the projection period.
Browse the market data and information spread across 116 pages with 33 data tables and 57 figures of the report “Stem Cell Manufacturing Market- Forecast 2018-2023” in-depth alongside table of content (TOC) at: https://www.marketresearchfuture.com/reports/stem-cell-manufacturing-market-6942
Latest Industry News:
- Celularity, clinical stage cell therapy firm, has entered a lease agreement for a site in New Jersey’s Florham Park, which would serve as the headquarters and comprise of advanced cell manufacturing facility.
- A Chinese life sciences company, Fosun Pharma, has struck a deal with a company working on stem-cell treatments for eye disease and strokes, ReNeuron, for licensing rights to two cell therapy programs.
- Novo Nordisk A/S, a Danish multinational pharmaceutical company, has subleased 44,000 square-foot facility from US biotech Asterias Biotherapeutics for USD 1 Mn to set up stem cell manufacturing facility.
Browse Related Reports:
Global Stem Cell Reconstructive Market Research Report: By Sources (Allogeneic, Autologous, Syngeneic), Cell Types (Embryonic Stem Cell, Adult Stem Cell), Application (Cancer, Diabetes, Traumatic Skin Defect, Severe Burn), End Users (Hospital, Research Institutes) - Forecast Till 2023
https://www.marketresearchfuture.com/reports/stem-cell-reconstructive-market-993
Global Stem Cell Assay Market Research Report: By-Products (Flow Cytometer), Technology (Micro Fabricated Assisted Technology), Assay (Cell Viability & Toxicity Assays), Application (Dermatology), End User (Biotechnology Industries) - Forecast Till 2023
https://www.marketresearchfuture.com/reports/stem-cell-assay-market-5656
Global Stem Cell Therapy Market Research Report, by Type (Allogeneic, Autologous), Product Type (Antibodies, Kits), Application (Clinical Research), End-User (Clinical Diagnostics, Hospitals & Research Institutes) - Global Forecast Till 2023
https://www.marketresearchfuture.com/reports/stem-cell-therapy-market-6422
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), & Consulting Services.
MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.
In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.
